Steven Cohen’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-25,000
Closed -$4.07M 1607
2019
Q2
$4.19M Buy
+25,000
New +$3.46M 0.02% 546
2019
Q1
Sell
-637,076
Closed -$85.2M 1328
2018
Q4
$85.2M Buy
637,076
+574,114
+912% +$94.1M 0.42% 61
2018
Q3
$12M Buy
62,962
+46,608
+285% +$8.56M 0.05% 427
2018
Q2
$2.73M Sell
16,354
-306,553
-95% -$49.2M 0.01% 720
2018
Q1
$54.3M Buy
+322,907
New +$54.2M 0.23% 120
2017
Q4
Sell
-449,776
Closed -$92.2M 1175
2017
Q3
$92.2M Buy
+449,776
New +$105M 0.41% 52
2017
Q2
Sell
-130,000
Closed -$31.1M 1075
2017
Q1
$31.1M Buy
130,000
+45,899
+55% +$10.7M 0.17% 158
2016
Q4
$17.7M Buy
+84,101
New +$17.4M 0.12% 206
2016
Q1
Sell
-73,200
Closed -$22.9M 906
2015
Q4
$22.9M Buy
+73,200
New +$21.8M 0.19% 146
2015
Q2
Sell
-3,783
Closed -$1.13M 914
2015
Q1
$1.13M Buy
3,783
+2,283
+152% +$651K 0.01% 611
2014
Q4
$386K Sell
1,500
-101,400
-99% -$25.3M ﹤0.01% 627
2014
Q3
$24.8M Buy
102,900
+77,900
+312% +$17.4M 0.19% 153
2014
Q2
$5.58M Buy
+25,000
New +$5.18M 0.04% 438

Other funds holding AGN

Steven Cohen's AGN Position: Q3 2019 in Review

Steven Cohen sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 25,000 shares — an estimated $4.07M sold.

Steven Cohen first reported a position in AGN in Q2 2014 and held it in 13 quarters. The position peaked at $92.2M in Q3 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Steven Cohen reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Steven Cohen sold 25,000 Allergan plc shares in Q3 2019, an estimated $4.07M.
  • Steven Cohen first reported a position in Allergan plc in Q2 2014 and held it in 13 quarters.
  • Steven Cohen's Allergan plc position peaked at $92.2M in Q3 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.